文献速递脑血管病

血管紧张素II肽疫苗通过减少氧化应激保护缺血脑组织

Angiotensin II Peptide Vaccine Protects Ischemic Brain Through Reducing Oxidative Stress.
PubMed 文献 · Stroke · 2017-03-31

研究在大鼠永久性大脑中动脉闭塞模型中评估血管紧张素II(Ang II)肽疫苗的作用。接种疫苗成功产生血清抗Ang II抗体且不改变血压,充分产生抗体可减少梗死体积、抑制Ang II 1型受体mRNA表达,并减少氧化应激和神经退行性标志物。结论提示Ang II疫苗接种通过抗体渗透至缺血脑组织阻断肾素-血管紧张素系统,发挥神经保护和抗氧化作用。

要点

  • Ang II肽疫苗接种可产生抗Ang II抗体而不影响血压。
  • 充分抗体产生减少永久性大脑中动脉闭塞大鼠的梗死体积。
  • 疫苗减少氧化应激和神经退行性标志物,具神经保护作用。

核心结论

  • Ang II疫苗接种通过抗体渗透至缺血脑组织阻断肾素-血管紧张素系统,发挥神经保护和抗氧化作用。
  • Ang II肽疫苗接种可能是治疗缺血性卒中的有前景的方法。

研究设计与样本

  • 雄性Wistar大鼠接受3次Ang II肽疫苗注射后行永久性大脑中动脉闭塞。
  • 检测血清或脑内抗Ang II抗体水平,并通过梗死体积、脑肾素-血管紧张素系统组分及神经退行性和氧化应激标志物评估疫苗效果。

主要发现

  • Ang II疫苗接种成功产生血清抗Ang II抗体,血压无伴随变化。
  • 充分产生血清抗Ang II抗体导致梗死体积减少,并诱导抗Ang II抗体渗透至缺血半球,抑制Ang II 1型受体mRNA表达。
  • 充分产生抗体的接种大鼠显示Fluoro-Jade B阳性细胞、血影蛋白片段化、4-羟基壬烯醛阳性细胞和Nox 2 mRNA表达减少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Medication nonadherence is one of major risk factors for the poor outcome in ischemic stroke. Vaccination is expected to solve such a problem because of its long-lasting effects, but its effect on ischemic brain damage is still unknown. Here, we focused on vaccination for renin-angiotensin system and examined the effects of angiotensin II (Ang II) peptide vaccine in permanent middle cerebral artery occlusion model in rats. METHODS: Male Wistar rats were exposed to permanent middle cerebral artery occlusion after 3× injections of Ang II peptide vaccine, and the serum or brain level of anti-Ang II antibody was examined. The effects of the vaccine were evaluated by differences in infarction volume, brain renin-angiotensin system components, and markers for neurodegeneration and oxidative stress. RESULTS: Ang II vaccination successfully produced anti-Ang II antibodies in serum without concomitant change in blood pressure. Sufficient production of serum anti-Ang II antibody led to reduction of infarct volume and induced the penetration of anti-Ang II antibody in ischemic hemisphere, with suppressed expression of Ang II type 1 receptor mRNA. Vaccinated rats with sufficient antibody production showed the reduction of Fluoro-Jade B-positive cells, spectrin fragmentation, 4-hydroxynonenal-positive cells, and Nox 2 mRNA expression. CONCLUSIONS: Our findings indicate that Ang II vaccination exerts neuroprotective and antioxidative effects in cerebral ischemia, with renin-angiotensin system blockade by penetration of anti-Ang II antibodies into ischemic brain lesion. Ang II peptide vaccination could be a promising approach to treat ischemic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Wakayama K, Shimamura M, Suzuki JI, et al. Angiotensin II Peptide Vaccine Protects Ischemic Brain Through Reducing Oxidative Stress. Stroke. 2017. PMID: 28364024. doi:10.1161/STROKEAHA.116.016269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。